Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.


The Blog

Selected category: Partnership

Back to overview

Product lifecycle management: why you should consider selecting an OEM partner

By David Keller

As a healthcare instrument moves through its lifecycle, its engineering, development and customer support need to progress in parallel. In order to extend a product’s profitability for as long as possible and to maintain customer...

Read more

Product lifecycle management: why it matters for the IVD industry

By David Keller

Developing an effective product lifecycle management (LCM) process is no longer just a ‘nice to have’ for manufacturers in the medical and diagnostics equipment industry, but an essential ‘must have’ to ensure long-term business...

Read more

Five secrets to a successful IVD OEM partnership

By Nicholas Smith

You are considering an Original Equipment Manufacturing (OEM) partner to support you in bringing your idea to market. The planned in vitro diagnostic device may require components, robotics and modules. You may need integration...

Read more

Reducing risks in IVD instrument development

By Nicholas Smith 

The In Vitro Diagnostics (IVD) medical device market is fast-paced and highly competitive, with new and advanced applications appearing every day. High technical risks, cost overruns, schedule delays and missed end-user targets...

Read more

Seven elements for successful IVD instrument development with your OEM partner

By Nicholas Smith 

You have made the decision to enter into the development of an IVD medical device for your customers. You have learned that inviting an OEM partner into your project could be beneficial to reduce risks and fill expertise or skill...

Read more

Things to consider before introducing lab automation to in vitro diagnostics

By Nicholas Smith 

If you’re thinking about automating your in vitro diagnostic (IVD) product it can be hard to decide whether to outsource to an Original Equipment Manufacturing (OEM) partner or keep the development in-house. While the familiarity...

Read more

The ups and downs of DIY lab automation

By Nicholas Smith

With open source software and high quality off-the-shelf components, do-it-yourself (DIY) lab automation solutions are trending. While developing lab automation in-house might seem attractive at first glance, the road is littered...

Read more

Why you should consider product lifecycle management when selecting an OEM partner

By Micaela Wochner

As a diagnostic product moves through its lifecycle, its development, engineering and customer support needs change. In order to extend the period of product profitability and customer loyalty for as long as possible, you must...

Read more

Molecular diagnostics – a closer look at sample to answer

By Nicolas Smith

How to overcome challenges like inefficient workflow and a lack of suitably trained staff is the question increasingly facing laboratories in markets ranging from diagnostics to food and beverages. Could sample-to-answer systems be...

Read more

Three considerations for reducing risk of ‘just-in-time’ inventory control

By Severin Heynen

As labs face tighter profit margins and the need to minimize cost of goods, there is increasing pressure to implement more efficient and responsive mechanisms for procurement and inventory management. A large proportion of annual...

Read more

How to secure long-term performance of OEM components for automated liquid handling

By Claudio Bui

When you design a complex laboratory automation system or device, every OEM liquid handling component that you integrate into it should be reliable, dependable and expected to perform to the highest industry standards. Subpar quality...

Read more

The next giant in genome sequencing? China

By Nicholas Smith

As  sequencing grows significantly in China, how are Chinese home-grown companies making the most of it?

In December 2017, the UK and China announced a joint initiative to advance collaboration in science and innovation¹. The...

Read more

Navigating the Future of Laboratory Developed Tests - The Impact of New FDA Guidance

By Nicholas Smith

Uncertainty and concern best describe the prevailing feelings of many researchers, clinicians, and companies that develop, manufacture, and implement laboratory developed tests (LDTs). The reason for all this uncertainty is the...

Read more

The leader in next generation immunodiagnostics

By Nicholas Smith

Jeff Bishop, Vice President, Research & Development, Singulex, explains the proprietary single molecule counting (SMC™) technology which has become today’s gold standard for immunoassay technology.

Read more